Two new studies found that a new, FDA-approved approach to cataract surgery is safer and more efficient that the standard procedure today, according to findings presented at the 115th Annual Meeting of the American Academy of Ophthalmology.
The method uses a femtosecond laser and is not widely available in the United States. One study found a 45 percent reduction in ultrasound energy and a 45 percent reduction in surgical manipulation of the eye when comparing laser pre-treatment to the standard procedure.
The second study looked at the loss of corneal endothelial cells following cataract surgery and found no cell loss in eyes treated with the femtosecond laser but a 1-7 percent loss with the standard treatment.
Related Articles about Cataracts:
Cataract Surgeon Dr. John Kim Joins Inland Eye Institute
Live Broadcast of Cataract Surgery, Laser Technology & Giving Back to the Community: Q&A With Dr. Kerry Solomon of Physicians' Eye Surgery Center
New Drug Could Prevent Cataract Blindness
The method uses a femtosecond laser and is not widely available in the United States. One study found a 45 percent reduction in ultrasound energy and a 45 percent reduction in surgical manipulation of the eye when comparing laser pre-treatment to the standard procedure.
The second study looked at the loss of corneal endothelial cells following cataract surgery and found no cell loss in eyes treated with the femtosecond laser but a 1-7 percent loss with the standard treatment.
Related Articles about Cataracts:
Cataract Surgeon Dr. John Kim Joins Inland Eye Institute
Live Broadcast of Cataract Surgery, Laser Technology & Giving Back to the Community: Q&A With Dr. Kerry Solomon of Physicians' Eye Surgery Center
New Drug Could Prevent Cataract Blindness